1121348

Summit Biosciences Inc. — FEI 3007577023

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 4, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, KY (United States)